{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:56:29Z","timestamp":1792634189881,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-024-00602-9","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:05:55Z","timestamp":1732075555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Minibioreactor arrays to model microbiome response to alcohol and tryptophan in the context of alcohol-associated liver disease"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-7630","authenticated-orcid":false,"given":"Wanchao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine","family":"Naimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Trainel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Li\u00e9vin-Le Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Perlemuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-769X","authenticated-orcid":false,"given":"Benoit","family":"Chassaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Ciocan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Cassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"602_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572\u20131585 (2011).","journal-title":"Gastroenterology"},{"key":"602_CR2","doi-asserted-by":"publisher","unstructured":"Mackowiak, B., Fu, Y., Maccioni, L. & Gao, B. Alcohol-associated liver disease. J. Clin. Invest. 134, https:\/\/doi.org\/10.1172\/jci176345 (2024).","DOI":"10.1172\/jci176345"},{"key":"602_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","volume":"75","author":"A Mirijello","year":"2015","unstructured":"Mirijello, A. et al. Identification and management of alcohol withdrawal syndrome. Drugs 75, 353\u2013365 (2015).","journal-title":"Drugs"},{"key":"602_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/hep.23009","volume":"50","author":"R Rao","year":"2009","unstructured":"Rao, R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50, 638\u2013644 (2009).","journal-title":"Hepatology"},{"key":"602_CR5","first-page":"163","volume":"38","author":"F Bishehsari","year":"2017","unstructured":"Bishehsari, F. et al. Alcohol and gut-derived inflammation. Alcohol. Res. 38, 163\u2013171 (2017).","journal-title":"Alcohol. Res."},{"key":"602_CR6","doi-asserted-by":"publisher","unstructured":"Maccioni, L. et al. Alcohol-associated bowel disease: new insights into pathogenesis. eGastroenterology 1, https:\/\/doi.org\/10.1136\/egastro-2023-100013 (2023).","DOI":"10.1136\/egastro-2023-100013"},{"key":"602_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"},{"key":"602_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577 (2020).","journal-title":"J. Hepatol."},{"key":"602_CR9","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1021\/acs.jafc.2c00633","volume":"70","author":"Q Xu","year":"2022","unstructured":"Xu, Q. et al. Propionate ameliorates alcohol-induced liver injury in mice via the gut-liver axis: focus on the improvement of intestinal permeability. J. Agric. Food Chem. 70, 6084\u20136096 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"602_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","volume":"66","author":"G Ferrere","year":"2017","unstructured":"Ferrere, G. et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J. Hepatol. 66, 806\u2013815 (2017).","journal-title":"J. Hepatol."},{"key":"602_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/gutjnl-2020-321565","volume":"70","author":"L Wrzosek","year":"2021","unstructured":"Wrzosek, L. et al. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut 70, 1299\u20131308 (2021).","journal-title":"Gut"},{"key":"602_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus, A., Planchais, J. & Sokol, H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23, 716\u2013724 (2018).","journal-title":"Cell Host Microbe"},{"key":"602_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx, T. et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut 68, 1504\u20131515 (2019).","journal-title":"Gut"},{"key":"602_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","volume":"19","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 19, 227\u2013239 (2016).","journal-title":"Cell Host Microbe"},{"key":"602_CR15","doi-asserted-by":"publisher","unstructured":"Lamas, B. et al. Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Sci. Transl. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.aba0624 (2020).","DOI":"10.1126\/scitranslmed.aba0624"},{"key":"602_CR16","doi-asserted-by":"publisher","unstructured":"Choi, S. C. et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci. Transl. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.aax2220 (2020).","DOI":"10.1126\/scitranslmed.aax2220"},{"key":"602_CR17","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3389\/fmicb.2018.01736","volume":"9","author":"H Liang","year":"2018","unstructured":"Liang, H. et al. Dietary L-tryptophan modulates the structural and functional composition of the intestinal microbiome in weaned piglets. Front Microbiol. 9, 1736 (2018).","journal-title":"Front Microbiol."},{"key":"602_CR18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00306.2023","author":"GH Rueda","year":"2024","unstructured":"Rueda, G. H. et al. Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial. Am. J. Physiol. Gastrointest. Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.00306.2023 (2024).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"602_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj, J. S. Alcohol, liver disease and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 16, 235\u2013246 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"602_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-4939-6361-4_18","volume":"1476","author":"JM Auchtung","year":"2016","unstructured":"Auchtung, J. M., Robinson, C. D., Farrell, K. & Britton, R. A. MiniBioReactor Arrays (MBRAs) as a tool for studying C. difficile physiology in the presence of a complex community. Methods Mol. Biol. (Clifton, N. J.) 1476, 235\u2013258 (2016).","journal-title":"Methods Mol. Biol. (Clifton, N. J.)"},{"key":"602_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0106-5","volume":"3","author":"JM Auchtung","year":"2015","unstructured":"Auchtung, J. M., Robinson, C. D. & Britton, R. A. Cultivation of stable, reproducible microbial communities from different fecal donors using minibioreactor arrays (MBRAs). Microbiome 3, 42 (2015).","journal-title":"Microbiome"},{"key":"602_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu, C. L. & Schnabl, B. The gut-liver axis and gut microbiota in health and liver disease. Nat. Rev. Microbiol. 21, 719\u2013733 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"602_CR23","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. USA 111, E4485\u2013E4493 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"602_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34054-6","volume":"13","author":"JT Wolstenholme","year":"2022","unstructured":"Wolstenholme, J. T. et al. Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice. Nat. Commun. 13, 6198 (2022).","journal-title":"Nat. Commun."},{"key":"602_CR25","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/j.clnu.2021.03.029","volume":"40","author":"C Amadieu","year":"2021","unstructured":"Amadieu, C. et al. Dietary fiber deficiency as a component of malnutrition associated with psychological alterations in alcohol use disorder. Clin. Nutr. 40, 2673\u20132682 (2021).","journal-title":"Clin. Nutr."},{"key":"602_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcmgh.2021.08.014","volume":"13","author":"M Qian","year":"2021","unstructured":"Qian, M. et al. Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease. Cell. Mol. Gastroenterol. Hepatol. 13, 233\u2013256 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"602_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/em.20588","volume":"52","author":"KT Chung","year":"2011","unstructured":"Chung, K. T. & Gadupudi, G. S. Possible roles of excess tryptophan metabolites in cancer. Environ. Mol. Mutagen 52, 81\u2013104 (2011).","journal-title":"Environ. Mol. Mutagen"},{"key":"602_CR28","doi-asserted-by":"publisher","first-page":"1140054","DOI":"10.3389\/fnut.2023.1140054","volume":"10","author":"D Hu","year":"2023","unstructured":"Hu, D. et al. Tryptophan intake, not always the more the better. Front Nutr. 10, 1140054 (2023).","journal-title":"Front Nutr."},{"key":"602_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect. Microbiol. 8, 13 (2018).","journal-title":"Front Cell Infect. Microbiol."},{"key":"602_CR30","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1681\/ASN.2022020189","volume":"33","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Expansion of escherichia-shigella in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy. J. Am. Soc. Nephrol. 33, 2276\u20132292 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"602_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.nut.2018.10.002","volume":"60","author":"C Kong","year":"2019","unstructured":"Kong, C., Gao, R., Yan, X., Huang, L. & Qin, H. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition 60, 175\u2013184 (2019).","journal-title":"Nutrition"},{"key":"602_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10096-011-1395-7","volume":"31","author":"MJ van den Beld","year":"2012","unstructured":"van den Beld, M. J. & Reubsaet, F. A. Differentiation between Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli. Eur. J. Clin. Microbiol Infect. Dis. 31, 899\u2013904 (2012).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"602_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nmni.2017.09.003","volume":"21","author":"NK Devanga Ragupathi","year":"2018","unstructured":"Devanga Ragupathi, N. K., Muthuirulandi Sethuvel, D. P., Inbanathan, F. Y. & Veeraraghavan, B. Accurate differentiation of Escherichia coli and Shigella serogroups: challenges and strategies. N. Microbes N. Infect. 21, 58\u201362 (2018).","journal-title":"N. Microbes N. Infect."},{"key":"602_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3109\/00365528309182111","volume":"18","author":"P Staun-Olsen","year":"1983","unstructured":"Staun-Olsen, P., Bj\u00f8rneboe, M., Prytz, H., Thomsen, A. C. & Orskov, F. Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum IgA. Scand. J. Gastroenterol. 18, 889\u2013896 (1983).","journal-title":"Scand. J. Gastroenterol."},{"key":"602_CR35","first-page":"223","volume":"37","author":"PA Engen","year":"2015","unstructured":"Engen, P. A., Green, S. J., Voigt, R. M., Forsyth, C. B. & Keshavarzian, A. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 37, 223\u2013236 (2015).","journal-title":"Alcohol Res."},{"key":"602_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","volume":"18","author":"R Ganesan","year":"2024","unstructured":"Ganesan, R. et al. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease. Hepatol. Int. 18, 486\u2013499 (2024).","journal-title":"Hepatol. Int."},{"key":"602_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/1078-0432.CCR-23-0195","volume":"30","author":"A Rodr\u00edguez-Garc\u00eda","year":"2024","unstructured":"Rodr\u00edguez-Garc\u00eda, A. et al. Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clin. Cancer Res. 30, 904\u2013917 (2024).","journal-title":"Clin. Cancer Res."},{"key":"602_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","volume":"72","author":"C Michaudel","year":"2023","unstructured":"Michaudel, C. et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut 72, 1296\u20131307 (2023).","journal-title":"Gut"},{"key":"602_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000777","author":"T Yamazaki","year":"2024","unstructured":"Yamazaki, T. et al. Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis. Hepatology https:\/\/doi.org\/10.1097\/hep.0000000000000777 (2024).","journal-title":"Hepatology"},{"key":"602_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4137\/IJTR.S2129","volume":"2","author":"DM Richard","year":"2009","unstructured":"Richard, D. M. et al. L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int. J. Tryptophan Res. 2, 45\u201360 (2009).","journal-title":"Int. J. Tryptophan Res."},{"key":"602_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/10408398.2017.1357534","volume":"59","author":"J Ka\u0142u\u017cna-Czapli\u0144ska","year":"2019","unstructured":"Ka\u0142u\u017cna-Czapli\u0144ska, J., G\u0105tarek, P., Chirumbolo, S., Chartrand, M. S. & Bj\u00f8rklund, G. How important is tryptophan in human health? Crit. Rev. Food Sci. Nutr. 59, 72\u201388 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"602_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00996-6","volume":"9","author":"S Naimi","year":"2021","unstructured":"Naimi, S., Viennois, E., Gewirtz, A. T. & Chassaing, B. Direct impact of commonly used dietary emulsifiers on human gut microbiota. Microbiome 9, 66 (2021).","journal-title":"Microbiome"},{"key":"602_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01724-6","volume":"12","author":"E Bonazzi","year":"2024","unstructured":"Bonazzi, E. et al. Individualized microbiotas dictate the impact of dietary fiber on colitis sensitivity. Microbiome 12, 5 (2024).","journal-title":"Microbiome"},{"key":"602_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/ajcn\/26.8.831","volume":"26","author":"CH Halsted","year":"1973","unstructured":"Halsted, C. H., Robles, E. A. & Mezey, E. Distribution of ethanol in the human gastrointestinal tract. Am. J. Clin. Nutr. 26, 831\u2013834 (1973).","journal-title":"Am. J. Clin. Nutr."},{"key":"602_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"602_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"602_CR47","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.8004808","author":"N Bokulich","year":"2023","unstructured":"Bokulich, N. et al. bokulich-lab\/RESCRIPt: 2023.5.0. Zenodo https:\/\/doi.org\/10.5281\/zenodo.8004808 (2023).","journal-title":"Zenodo"},{"key":"602_CR48","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00602-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:02:53Z","timestamp":1732078973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00602-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1038\/s41522-024-00602-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4383814\/v1","asserted-by":"object"}]},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.C. received travel funds from Biocodex and Gilead, lecture fees from Gilead, and royalties from John Libbey Eurotext. G.P. received travel funds from Janssen and Gilead, consulting fees from Bayer, Biocodex, Roche, Gilead, Pierre Fabre, and Servier, and royalties from Elsevier-Masson, Solar, Flammarion\/Versilio, and John Libbey Eurotext. A.M.C. received royalties from Elsevier-Masson, Solar, Flammarion\/Versilio, and John Libbey Eurotext. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}